Chiropractors in Kahoka, MO Accepting Medicare
4 Chiropractors found. Showing 1 - 4
 Dr. Kelley R Kirchner, D. C. Chiropractor - Internist Medicare: Medicare Enrolled Practice Location: 374 W Commercial St, Kahoka, MO 63445 Phone: 660-727-3677 Fax: 660-727-2222 |
 Kirchner Clinic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 374 W Commercial St, Kahoka, MO 63445 Phone: 660-727-3677 Fax: 660-727-2222 |
 Dr. Darren Evan Kirchner, D.C. Chiropractor - Internist Medicare: Medicare Enrolled Practice Location: 374 W Commercial St, Kahoka, MO 63445 Phone: 660-727-3677 Fax: 660-727-2222 |
Kirchner Clinic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 374 W Commercial St, Kahoka, MO 63445 Phone: 660-727-3677 |
News Archive
Three health systems form new initiative to improve healthcare services
Abington Health, Aria Health and Einstein Healthcare Network announced today the development of a new initiative that will enable the three health systems to work collaboratively while remaining independent as they prepare for the demands of national health reform.
Stony Brook team creates live attenuated influenza virus vaccine by computer-aided rational design
A team of molecular biologists and computer scientists at Stony Brook University have used a novel method to weaken (attenuate) influenza virus by way of designing hundreds of mutations to its genetic code to create an effective vaccine. Reported online and in the July issue of Nature Biotechnology, the method may be a major step in developing more effective and safe vaccines against influenza, which claims 250,000 to 500,000 lives annually worldwide, partly because existing vaccines are not fully effective.
Postponing chemotherapy may increase risk of death for triple-negative breast cancer patients
Postponing the start of adjuvant chemotherapy for more than 90 days following surgery may significantly increase risk of death for breast cancer patients, particularly those with triple-negative breast cancer (TNBC), according to a new study from The University of Texas MD Anderson Cancer Center.
Anti-nausea drug Zofran being tested for its potential heart rhythm side effects
The United States health regulators Food and Drug Administration (FDA) are looking at the safety of GlaxoSmithKline's anti-nausea drug Zofran generically known as ondansetron, to ascertain whether there is a potential risk of abnormal heart rhythm.
Largest ever analysis of DES data demonstrates safety, efficacy in on-and-off-label use
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
› Verified 9 days ago
Physical Therapists
Chiropractors
Speech-Language Pathologists
Occupational Therapists